Format
Sort by

Send to

Choose Destination

Links from PubChem BioAssay

Items: 6

1.

Deubiquitinating enzymes as novel anticancer targets.

Nicholson B, Marblestone JG, Butt TR, Mattern MR.

Future Oncol. 2007 Apr;3(2):191-9. Review.

2.

The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2.

Stevenson LF, Sparks A, Allende-Vega N, Xirodimas DP, Lane DP, Saville MK.

EMBO J. 2007 Feb 21;26(4):976-86.

3.

The isopeptidase USP2a protects human prostate cancer from apoptosis.

Priolo C, Tang D, Brahamandan M, Benassi B, Sicinska E, Ogino S, Farsetti A, Porrello A, Finn S, Zimmermann J, Febbo P, Loda M.

Cancer Res. 2006 Sep 1;66(17):8625-32.

4.

A genomic and functional inventory of deubiquitinating enzymes.

Nijman SM, Luna-Vargas MP, Velds A, Brummelkamp TR, Dirac AM, Sixma TK, Bernards R.

Cell. 2005 Dec 2;123(5):773-86. Review.

5.

Mechanism and function of deubiquitinating enzymes.

Amerik AY, Hochstrasser M.

Biochim Biophys Acta. 2004 Nov 29;1695(1-3):189-207. Review.

6.

The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer.

Graner E, Tang D, Rossi S, Baron A, Migita T, Weinstein LJ, Lechpammer M, Huesken D, Zimmermann J, Signoretti S, Loda M.

Cancer Cell. 2004 Mar;5(3):253-61.

Items per page

Supplemental Content

Support Center